Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects

Tissue Engineering - Part C: Methods

Volumn 16, Issue 2, 2010, Pages 201-214

  Salvadè, Agnese ^a,b   Mina, Pamela Della ^a,c   Gaddi, Diego ^b   Gatto, Francesca ^b   Villa, Antonello ^a   Bigoni, Marco ^b   Perseghin, Paolo ^b   Serafini, Marta ^b   Zatti, Giovanni ^b   Biondi, Andrea ^a   Biagi, Ettore ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BLOOD SUBSTITUTES; BODY FLUIDS; BONE; FLOWCHARTING; GELS; GENE EXPRESSION; HYDROXYAPATITE; PLATELETS; POLYMERASE CHAIN REACTION; POPULATION STATISTICS; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; TISSUE CULTURE; TISSUE ENGINEERING;

BONE DEFECT; BONE REGENERATION; BONE REPAIR; CELL TRANSFORMATION; CLINICAL USE; COLONY FORMING UNITS; DOUBLINGS; FETAL BOVINE SERUM; GENE EXPRESSION ANALYSIS; GOOD MANUFACTURING PRACTICES; GROWTH FACTOR; LARGE SCALE EXPERIMENTS; MESENCHYMAL STROMAL CELLS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; SCANNING ELECTRONS;

CELL CULTURE;

BOVINAE;

CELL EXTRACT;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE PROSTHESIS; BONE REGENERATION; CATTLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CHEMISTRY; CLONOGENIC ASSAY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; METHODOLOGY; ORTHOPEDIC EQUIPMENT; PHYSIOLOGY; STROMA CELL; SYNTHESIS; THROMBOCYTE; TISSUE ENGINEERING; VALIDATION STUDY;

ANIMALS; BLOOD PLATELETS; BONE DISEASES; BONE REGENERATION; BONE SUBSTITUTES; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL EXTRACTS; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA; HL-60 CELLS; HUMANS; MESENCHYMAL STEM CELLS; ORTHOPEDIC EQUIPMENT; OSTEOGENESIS; STROMAL CELLS; TISSUE ENGINEERING;

EID: 77952376195     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2008.0572     Document Type: Article

References (69)

1. Prockop, D.J. Marrow stromal cells as stem cells from non-hematopoietic tissues. Science 276, 71, 1997.
2. Caplan, A.I. The mesengenic process. Clin Plast Surg 21, 429, 1994.
3. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
4. Bianco, P., and Robey PG. Marrow stromal stem cells. J Clin Invest 105, 1663, 2000.
5. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
6. Zuk, P.A., Zhu, M., Ashjian, P., de Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multi-potent stem cells. Mol Biol Cell 13, 4279, 2002.
7. Campagnoli, C., Roberts, I.A., Kumar, S., Bennett, P.R., Bellantuono, I., and Fisk, N.M. Identification of mesenchy-mal stem=progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98, 2396, 2001.
8. In't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H., Willemze, R., Fibbe W.E., and Kanhai, H.H. Amniotic fluid as a novel source of mesen-chymal stem cells for therapeutic transplantation. Blood 102, 1548, 2003.
9. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive sub-cultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
10. Colter, D.C., Class, R., DiGirolamo, C.M., and Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97, 3213, 2000.
11. Qi, H., Aguiar, D.J., Williams, S.M., La Pean, A., Pan, W., and Verfaillie, C.M. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA 100, 3305, 2003.
12. Frank, O., Heim, M., Jakob, M., Barbero, A., Schäfer D., Bendik, I., Dick, W., Heberer, M., and Martin, I. Real-time quantitative RT-PCR analysis of human bone marrow stro-mal cells during osteogenic differentiation in vitro. J Cell Biochem 85, 737, 2002.
13. Seebach, C., Henrich, D., Tewksbury, R., Wilhelm, K., and Marzi, I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int 80, 294, 2007.
14. Hofmann, A., Ritz, U., Hessmann, M.H., Schmid, C., Tresch, A., Rompe, J.D., Meurer, A., and Rommens, P.M. Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions. Bone 42, 894, 2008.
15. Fleming, J.E., Cornell, C.N., and Muschler, G.F. Bone cells and matrices in orthopaedic tissue engineering. Orthop Clin North Am 31, 357, 2000.
16. Bauer, T.W., and Muschler, G.F. Bone graft materials. An overview of the basic science. Clin Orthop 371, 10, 2000.
17. Einhorn, T.A., Majeska, R.J., Mohaideen, A., Kagel, E.M., Bouxsein, M.L., Turek, T.J., and Wozney, J.M. A single percutaneous injection of recombinant human bone mor-phogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 85, 1425, 2003.
18. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
19. Healey, J.H., Zimmerman, P.A., McDonnell, J.M., and Lane, J.M. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 256, 280, 1990.
20. Aaron, R.K., and Ciombor, D.M. Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool. J Orthop Res 14, 582, 1996.
21. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
22. Kon, E., Muraglia, A., Corsi, A., Bianco, P., Marcacci, M., Martin, I., Boyde, A., Ruspantini, I., Chistolini, P., Rocca, M., Giardino, R., Cancedda, R., and Quarto R. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49, 328, 2000.
23. Cancedda, R., Dozin, B., Giannoni, P., and Quarto, R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22, 81, 2003.
24. Giannoni, P., Mastrogiacomo, M., Alini, M., Pearce, S.G., Corsi, A., Santolini, F., Muraglia, A., Bianco, P., and Can-cedda, R. Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regen Med 2, 253, 2008.
25. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., and Guillemin, G. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
26. Kanczler, J.M., and Oreffo, R.O. Osteogenesis and angio-genesis: the potential for engineering bone. Eur Cell Mater 15, 100, 2008.
27. Zelzer, E., McLean, W., Ng, Y.S., Fukai, N., Reginato, A.M., Lovejoy, S., D'Amore, P.A., and Olsen, B.R. Skeletal defects in VEGF(120=120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893, 2002.
28. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
29. Lucarelli, E., Fini, M., Beccheroni, A., Giavaresi, G., Di Bella, C., Aldini, N.N., Guzzardella, G., Martini, L., Cenacchi, A., Di Maggio, N., Sangiorgi, L., Fornasari, P.M., Mercuri, M., Giardino, R., and Donati, D. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res 435, 62, 2005.
30. Weibrich, G., Kleis, W.K., Hafner, G., and Hitzler, W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30, 97, 2002.
31. Perseghin, P., Sciorelli, G., Belotti, D., Speranza, T., Pogliani, E.M., Ferro, O., Gianoli, M., Porta, F., and Paolini, G. Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds. Transfusion 45, 1544, 2005.
32. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
33. Maloney, J.P., Silliman, C.C., Ambruso, D.R., Wang, J., Tuder, R.M., and Voelkel, N.F. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 275, H1054, 1998.
34. Lucarelli, E., Beccheroni, A., Donati, D., Sangiorgi, L., Cenacchi, A., Del Vento, A.M., Meotti, C., Bertoja, A.Z., Giardino, R., Fornasari, P.M., Mercuri, M., and Picci, P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24, 3095, 2003.
35. Giannoudis, P.V., and Pountos, I. Biology of mesenchymal stem cells. Injury 36, S8, 2005.
36. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
37. Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., Mastrogiacomo, M., and Cancedda, R. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng 13, 947, 2007.
38. Ohgushi, H., Kotobuki, N., Funaoka, H., Machida, H., Hirose, M., Tanaka, Y., and Takakura, Y. Tissue engineered ceramic artificial joint\ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26, 4654, 2005.
39. Burger, S.R. Design and operation of a current good manufacturing practices cell-engineering laboratory. Cyto-therapy 2, 111, 2000.
40. Salvadè, A., Belotti, D., Donzelli, E., D'Amico, G., Gaipa, G., Renoldi, G., Carini, F., Baldoni, M., Pogliani, E.M., Tredici, G., Biondi, A., and Biagi, E. GMPgrade preparation of bio-mimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease. Cytotherapy 9, 427, 2007.
41. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell based therapy applications. J Cell Physiol 205, 228, 2005.
42. Lange, C., Cakiroglu, F., Spiess, A.N., Cappallo-Obermann, H., Dierlamm, J., and Zander, A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213, 18, 2007.
43. Muller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M.P., Horwitz, E.M., Conte, P., Handgretinger, R., and Do-minici, M. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437, 2006.
44. Capelli, C., Domenghini, M., Borleri, G., Bellavita, P., Poma, R., Carobbio, A., Micò, C., Rambaldi, A., Golay, J., and In-trona, M. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 40, 785, 2007.
45. Bernardo, M.E., Avanzini, M.A., Perotti, C., Cometa, A.M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., de Silvestri, A., Amendola, G., Zuffardi, O., Maccario, R., and Locatelli, F. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211, 121, 2007.
46. Rubio, D., Garcia-Castro, J., Mart́?n, M.C., de la Fuente, R., Cigudosa, J.C., Lloyd, A.C., and Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res 65, 3035, 2005.
47. Miura, M., Miura, Y., Padilla-Nash, H.M. Molinolo, A.A., Fu, B., Patel, V., Seo, B.M., Sonoyama, W., Zheng, J.J., Baker, C.C., Chen, W., Ried, T., and Shi, S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095, 2006.
48. Bernardo, M.E., Zaffaroni, N., Novara, F., Cometa, A.M., Avanzini, M.A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M.G., Zuffardi, O., and Locatelli, F. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67, 9142, 2007.
49. Staples, O.D., Steele, R.J., and Lain, S. p53 as a therapeutic target. Surgeon 6, 240, 2008.
50. Castro-Malaspina, H., Gay, R.E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., McKenzie, S., Broxmeyer, H.E., and Moore, M.A. Characterization of human bone marrow fi-broblast colony-forming cells (CFU-F) and their progeny. Blood 56, 289, 1980.
51. Slichter, S.J., and Harker, L.A. Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol 34, 395, 1976.
52. Shaffer, L.G., and Tommerup, N. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger. Eds. ISCN 2005.
53. Biagi, E., Di Biaso, I., Leoni, V., Gaipa, G., Rossi, V., Bugarin, C., Renoldi, G., Parma, M., Balduzzi, A., Perseghin, P., and Biondi, A. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4\+CD25\+GITR\+ Foxp3\+CD62L\+functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 84, 31, 2007.
54. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402, 2001.
55. Zhang, Z.Y., Teoh, S.H., Chong, M.S., Schantz, J.T., Fisk, N.M., Choolani, M.A., and Chan, J. Superior osteogenic capacity for bone tissue engineering of fetal compared to perinatal and adult mesenchymal stem cells. Stem Cells 27, 126, 2009.
56. Kilian, O., Flesch, I., Wenisch, S., Taborski, B., Jork, A., Schnettler, R., and Jonuleit, T. Effects of platelet growth factors on human mesenchymal stem cells and human en-dothelial cells in vitro. Eur J Med Res 9, 337, 2004.
57. Tamama, K., Fan, V.H., Griffith, L.G., Blair, H.C., and Wells, A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem cells 24, 686, 2006.
58. Gruber, R., Karreth, F., Kandler, B., Fuerst, G., Rot, A., Fischer, M.B., and Watzek, G. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15, 29, 2004.
59. Younger, E.M., and Chapman, M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3, 192, 1989.
60. Aro, H.T., and Aho, A.J. Clinical use of bone allografts. Ann Med 25, 403, 1993.
61. Capelli, C., Salvadè, A., Pedrini, O., Barbui, V., Gotti, V., Boleri, G., Cabiati, B., Perseghin, P., Belotti, D., Bellavista, P., Biondi, A., Biagi, E., Rambaldi, A., Golay, J., and Introna, M. The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs expanded in GMP conditions. Cytotherapy 11, 403, 2009.
62. Shahdadfar, A., Frønsdal, K., Haug, T., Reinholt, F.P., and Brinchmann, J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357, 2005.
63. Stute, N., Holtz, K., Bubenheim, M., Lange, C., Blake, F., and Zander, A.R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp He-matol 32, 12, 2004.
64. Boskey, A.L. Matrix proteins and mineralization: an overview. Connect Tissue Res 35, 357, 1996.
65. Dimitriou, R., Tsiridis, E., and Giannoudis, P.V. Current concepts of molecular aspects of bone healing. Injury 36, 1392, 2005.
66. Wenz, B., Oesch, B., and Horst, M. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. Biomaterials 22, 1599, 2001.
67. Orr, T.E., Villars, P.A., Mitchell, S.L., Hsu, H.P., and Spector, M. Compressive properties of cancellous bone defects in a rabbit model treated with particles of natural bone mineral and synthetic hydroxyapatite. Biomaterials 22, 1953, 2001.
68. Sikavitsas, V.I., Bancroft, G.N., and Mikos, A.G. Formation of three-dimensional cell=polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62, 136, 2002.
69. Kim, H.J., Kim, U.J., Leisk, G.G., Bayan, C., Georgakoudi, I., and Kaplan, D.L. Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol Biosci 7, 643, 2007.